Showing 1,561 - 1,580 results of 60,818 for search '(( 5 ((nn decrease) OR (we decrease)) ) OR ( 50 ((ng decrease) OR (a decrease)) ))', query time: 0.97s Refine Results
  1. 1561
  2. 1562
  3. 1563
  4. 1564
  5. 1565
  6. 1566
  7. 1567
  8. 1568
  9. 1569
  10. 1570
  11. 1571

    Flow chart. by Raphaele Houlbracq (20558509)

    Published 2025
    “…The difference in overall prevalence of OASI between 2010 (0.7%) and 2021 (1.0%) was not statistically significant after adjustment (aRR 1.24, 95% CI 0.91 to 1.68). By groups of classification, the prevalence of OASI increased significantly only in Group 2b [nulliparous term cephalic singleton with spatula delivery] from 2.6% (95% CI 1.2 to 5.6) in 2010 to 9.6% (95% CI 6.2 to 14.7) in 2021 (aRR 3.69, 95% CI 1.50 to 9.09), and did not differ statistically significantly in Group 2a [nulliparous term cephalic singleton with forceps delivery] from 3.2% (95% CI 1.8 to 5.7) in 2010 to 5.7% (95% CI 3.4 to 9.5) in 2021 (aRR 1.78, 95% CI 0.81 to 3.90).…”
  12. 1572

    Data used to generate Fig 5. by Pattamaporn Kittayapong (289542)

    Published 2025
    “…However, this irradiation dose could be reduced to 5 Gy to sterilize both males and females infected with <i>Wolbachia</i>. …”
  13. 1573

    Data used to generate Table 5. by Pattamaporn Kittayapong (289542)

    Published 2025
    “…However, this irradiation dose could be reduced to 5 Gy to sterilize both males and females infected with <i>Wolbachia</i>. …”
  14. 1574
  15. 1575

    DataSheet_1_Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2.pdf by Yun Ji (464484)

    Published 2022
    “…However, the continuous virus evolution requires diverse mAb options to combat variants. Here we describe two fully human mAbs, amubarvimab (BRII-196) and romlusevimab (BRII-198) that bind to non-competing epitopes on the receptor binding domain (RBD) of spike protein and effectively neutralize SARS-CoV-2 variants. …”
  16. 1576

    DPT3 Stat EDHS for five surveys. by Hailu Fekadu (17797638)

    Published 2024
    “…Regarding educational status, inequality (RII) show decreasing pattern from 7.2% (2000) to 1.5% in(2019). …”
  17. 1577
  18. 1578

    Losartan Treatment Protects Retinal Ganglion Cells and Alters Scleral Remodeling in Experimental Glaucoma by Harry A. Quigley (695817)

    Published 2015
    “…</p><p>Methods</p><p>We produced IOP increase in CD1 mice and performed unilateral optic nerve crush. …”
  19. 1579
  20. 1580